A carregar...
Tolvaptan and its potential in the treatment of hyponatremia
Tolvaptan is a selective arginine vasopressin (AVP) V(2) receptor blocker used to induce free water diuresis in the treatment of euvolemic or hypervolemic hyponatremia. Currently the orally active medication is in the final stages prior to approval by the FDA for outpatient therapy. It appears to be...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2643096/ https://ncbi.nlm.nih.gov/pubmed/19337422 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|